Efficacy and safety of tunlametinib in patients with advanced NRAS-mutant melanoma: A multicenter, open-label, single-arm, phase 2 study.
- Resource Type
- Article
- Authors
- Si, Lu; Zou, Zhengyun; Zhang, Weizhen; Fang, Meiyu; Zhang, Xiaoshi; Luo, Zhiguo; Chen, Jing; Huang, Gang; Zhang, Peng; Cheng, Ying; Liu, Jiwei; Liu, Jiyan; Zhang, Junping; Wu, Di; Chen, Yu; Ma, Xiaobiao; Wei, Xiaoting; Sun, Peng; Jia, Zhongwei; Guo, Jun
- Source
- Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p9510-9510, 1p
- Subject
- Language
- ISSN
- 0732183X